Loading…

AVITA Medical (RCEL) backlog: remaining performance obligations

How much revenue AVITA Medical already has under contract, how fast it converts, and who it is with.

Data as of .

AVITA Medical backlog history

$0$25M$50M$75MDec 2022Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2026Sep 2026Backlog (RPO)Trailing 12-month revenue
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter endBacklog (RPO)TTM revenueCoverageCustomer prepayments
30 Sep 2026$300,000$84.7M0.0 yrs$300,000
30 Jun 2026$300,000$75.6M0.0 yrs$300,000
31 Mar 2026$300,000$72.3M0.0 yrs$300,000
31 Dec 2025$300,000$71.6M0.0 yrs$300,000
30 Sep 2025$300,000$72.4M0.0 yrs$300,000
30 Jun 2025$300,000$74.9M0.0 yrs$300,000
31 Mar 2025$300,000$71.7M0.0 yrs$300,000
31 Dec 2024$400,000$64.3M0.0 yrs$400,000
30 Sep 2024$400,000$60.0M0.0 yrsn/a
30 Jun 2024$500,000$54.1M0.0 yrsn/a
31 Mar 2024$400,000$50.7M0.0 yrs$400,000
31 Dec 2023$400,000$50.1M0.0 yrs$400,000

Questions

What is AVITA Medical's backlog?
AVITA Medical reported $300,000 of remaining performance obligations at 30 Sep 2026, flat from a year earlier and flat from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 1.00.

About these numbers

Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.